| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.94▲ | 3.97▼ | 3.98▼ | 4.10▼ | 4.19▼ |
| MA10 | 3.94▲ | 4.00▼ | 4.01▼ | 3.85▲ | 7.64▼ |
| MA20 | 3.95▼ | 4.03▼ | 4.04▼ | 4.32▼ | 10.63▼ |
| MA50 | 4.00▼ | 4.08▼ | 3.94▲ | 8.37▼ | 11.13▼ |
| MA100 | 4.02▼ | 3.89▲ | 3.97▼ | 10.66▼ | N/A |
| MA200 | 4.07▼ | 4.09▼ | 5.09▼ | 11.29▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.011▼ | -0.024▼ | 0.295▲ | -1.093▼ |
| RSI | 34.640▼ | 37.846▼ | 42.818▼ | 29.495▼ | 30.336▼ |
| STOCH | 79.167 | 13.651▼ | 17.647▼ | 61.780 | 4.822▼ |
| WILL %R | -25.000 | -85.000▼ | -85.000▼ | -63.804 | -95.547▼ |
| CCI | -8.642 | -169.959▼ | -193.508▼ | 4.674 | -85.014 |
|
Sunday, March 29, 2026 02:06 PM
Aardvark Therapeutics, Inc. (NASDAQ:AARD) is one of the penny stocks with potential to rise 1000 percent. Aardvark Therapeutics said on March 23, 2026, that it had voluntarily paused its Phase 3 HERO ...
|
|
Thursday, March 19, 2026 12:00 AM
NEW YORK, March 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aardvark Therapeutics, Inc. ("Aardvark" or the "Company") (NYSE: AARD). Such investors are ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/04/26 | 4.10 | 4.11 | 3.91 | 3.94 | 120,212 |
| 07/04/26 | 4.12 | 4.12 | 3.94 | 4.04 | 121,108 |
| 06/04/26 | 4.30 | 4.39 | 4.04 | 4.13 | 227,141 |
| 02/04/26 | 3.92 | 4.30 | 3.90 | 4.30 | 132,517 |
| 01/04/26 | 3.80 | 4.13 | 3.77 | 4.09 | 420,358 |
| 31/03/26 | 3.75 | 3.8989 | 3.49 | 3.77 | 389,479 |
| 30/03/26 | 3.58 | 3.72 | 3.4943 | 3.64 | 184,150 |
| 27/03/26 | 3.44 | 3.68 | 3.35 | 3.55 | 225,109 |
| 26/03/26 | 3.50 | 3.6599 | 3.405 | 3.51 | 262,835 |
| 25/03/26 | 3.88 | 3.88 | 3.52 | 3.54 | 249,164 |
|
|
||||
|
|
||||
|
|